Trials / Unknown
UnknownNCT04027595
Efficacy and Outcomes of Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy Performed by Optometrists
Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy: Efficacy and Outcomes Performed by Optometrists
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Northeastern State University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to formally assess the efficacy and outcomes of optometrist-performed neodymium-doped yttrium aluminum garnet (Nd: YAG) laser capsulotomy procedures.
Detailed description
Participants will undergo a pre-procedure examination to establish baseline findings and to determine if they meet the inclusion criteria. Participants will undergo the Nd: YAG laser capsulotomy procedure and will be examined at 1 hour, 1 day (if necessary), 1 week, 1 month, and 3 months following the procedure. Follow-up examinations will evaluate visual acuity improvement and possible post-procedure complications. The complication rate following the laser capsulotomy procedure is typically minimal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy | A Nd: YAG laser will be used to open the cloudy posterior capsule of the lens to improve central visual acuity. |
Timeline
- Start date
- 2019-09-17
- Primary completion
- 2022-05-22
- Completion
- 2022-09-30
- First posted
- 2019-07-22
- Last updated
- 2022-09-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04027595. Inclusion in this directory is not an endorsement.